← Leaderboards
Benjamin L. Shneider
Mount Sinai School Of Medicine Of Nyu
$11,813,759
Attributed
$12,113,759
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,513,759 · 9
FDA$600,000 · 1
By mechanism
U01$7,051,446 · 3
R01$4,720,760 · 3
R21$323,384 · 1
M01$18,169 · 3
Top collaborators
- Dennis Darrel Black4 shared
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Frederick J Suchy$8,245,458
Others in their field
Top investigators on “Liver Diseases”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Larry Arthur$49,271,333
Research focus
Liver DiseasesLiverChildBiliary AtresiaInvestigationCholestasisLiver TransplantationChildhoodLeadClinical TrialsInfantDiagnosisUnited StatesResearch PersonnelPathogenesisHepatologyBaseClinical ResearchSecondary OutcomeSerumCystic FibrosisAlagille SyndromeBile AcidsPattern
Grant awards (52)
BCM/TCH Cholestatic Liver Disease Consortium$347,915
U01 · FY2025 · DK · contact PI
BCM/TCH Cholestatic Liver Disease Consortium$350,000
U01 · FY2024 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$360,000
U01 · FY2023 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$431,947
U01 · FY2022 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$396,714
U01 · FY2021 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$361,048
U01 · FY2020 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$255,000
U01 · FY2020 · DK · contact PI
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM$189,332
U01 · FY2019 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$358,955
U01 · FY2018 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$328,823
U01 · FY2017 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$251,375
U01 · FY2017 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$313,313
U01 · FY2016 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$216,870
U01 · FY2015 · DK · contact PI
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$113,130
U01 · FY2015 · DK · contact PI
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing CholangitisA pilot$100,000
R01 · FY2015 · FD
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy$216,870
U01 · FY2014 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$292,256
R01 · FY2013 · DK · contact PI
The Pittsburgh Cholestatic Liver Disease Consortium$245,932
U01 · FY2013 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$8,502
R01 · FY2013 · DK · contact PI
Molecular regulation of ileal/renal bile acid transport$329,754
R01 · FY2012 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$311,219
R01 · FY2012 · DK · contact PI
The Pittsburgh Cholestatic Liver Disease Consortium$225,135
U01 · FY2012 · DK · contact PI
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing CholangitisA pilot$100,000
R01 · FY2012 · FD
Molecular regulation of ileal/renal bile acid transport$333,108
R01 · FY2011 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$311,219
R01 · FY2011 · DK · contact PI
The Pittsburgh Cholestatic Liver Disease Consortium$275,000
U01 · FY2011 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$378,750
R01 · FY2010 · DK · contact PI
Molecular regulation of ileal/renal bile acid transport$329,513
R01 · FY2010 · DK · contact PI
The Pittsburgh Cholestatic Liver Disease Consortium$267,518
U01 · FY2010 · DK · contact PI
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing CholangitisA pilot$200,000
R01 · FY2010 · FD
The Pittsburgh Cholestatic Liver Disease Consortium$154,068
U01 · FY2010 · DK · contact PI
The Pittsburgh Cholestatic Liver Disease Consortium$238,473
U01 · FY2009 · DK · contact PI
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing CholangitisA pilot$200,000
R01 · FY2009 · FD
Biliary Atresia Clinical Research Consortium: Pittsburgh$243,147
U01 · FY2008 · DK · contact PI
Molecular regulation of ileal/renal bile acid transport$272,128
R01 · FY2007 · DK · contact PI
Biliary Atresia Clinical Research Consortium: Pittsburgh$83,853
U01 · FY2007 · DK · contact PI
Molecular regulation of ileal/renal bile acid transport$277,555
R01 · FY2006 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$89,684
R21 · FY2006 · DK · contact PI
Molecular Mechanisms of Intrahepatic Cholestasis$64,200
R21 · FY2006 · DK · contact PI
Molecular regulation of ileal/renal bile acid transport$45,276
R01 · FY2006 · DK · contact PI
BILLARY ATRESIA (BA) CLINICAL RESEARCH-CORTICOSTEROID THERAPY IN INFANTS WITH BA$12,869
M01 · FY2006 · RR · contact PI
BILIARY ATRESIA CLINICAL RESEARCH CONSORTIUM$1,073
M01 · FY2006 · RR · contact PI
Molecular regulation of ileal/renal bile acid transport$339,000
R01 · FY2005 · DK
The Mount Sinai Biliary Atresia Study Group$245,010
U01 · FY2005 · DK
Molecular Mechanisms of Intrahepatic Cholestasis$169,500
R21 · FY2005 · DK
BILIARY ATRESIA CLINICAL RESEARCH CONSORTIUM$4,227
M01 · FY2005 · RR
Molecular regulation of ileal/renal bile acid transport$339,000
R01 · FY2004 · DK
The Mount Sinai Biliary Atresia Study Group$245,010
U01 · FY2004 · DK
Molecular regulation of ileal/renal bile acid transport$339,000
R01 · FY2003 · DK
The Mount Sinai Biliary Atresia Study Group$168,504
U01 · FY2003 · DK
The Mount Sinai Biliary Atresia Study Group$168,504
U01 · FY2002 · DK
MOLECULAR REGULATION OF ILEAL/RENAL BILE ACID TRANSPORT$214,480
R01 · FY2000 · DK